Literature DB >> 27063097

Glioma cell dispersion is driven by α5 integrin-mediated cell-matrix and cell-cell interactions.

Anne-Florence Blandin1, Fanny Noulet1, Guillaume Renner1, Marie-Cécile Mercier1, Laurence Choulier1, Romain Vauchelles1, Philippe Ronde1, Franck Carreiras2, Nelly Etienne-Selloum3, Gyorgy Vereb4, Isabelle Lelong-Rebel1, Sophie Martin1, Monique Dontenwill1, Maxime Lehmann5.   

Abstract

Glioblastoma multiform (GBM) is the most common and most aggressive primary brain tumor. The fibronectin receptor, α5 integrin is a pertinent novel therapeutic target. Despite numerous data showing that α5 integrin support tumor cell migration and invasion, it has been reported that α5 integrin can also limit cell dispersion by increasing cell-cell interaction. In this study, we showed that α5 integrin was involved in cell-cell interaction and gliomasphere formation. α5-mediated cell-cell cohesion limited cell dispersion from spheroids in fibronectin-poor microenvironment. However, in fibronectin-rich microenvironment, α5 integrin promoted cell dispersion. Ligand-occupied α5 integrin and fibronectin were distributed in fibril-like pattern at cell-cell junction of evading cells, forming cell-cell fibrillar adhesions. Activated focal adhesion kinase was not present in these adhesions but was progressively relocalized with α5 integrin as cell migrates away from the spheroids. α5 integrin function in GBM appears to be more complex than previously suspected. As GBM overexpressed fibronectin, it is most likely that in vivo, α5-mediated dissemination from the tumor mass overrides α5-mediated tumor cell cohesion. In this respect, α5-integrin antagonists may be useful to limit GBM invasion in brain parenchyma.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fibronectin; Focal adhesion kinase; Glioblastoma; Integrin; Migration

Mesh:

Substances:

Year:  2016        PMID: 27063097     DOI: 10.1016/j.canlet.2016.04.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  The multifaceted mechanisms of malignant glioblastoma progression and clinical implications.

Authors:  Rui Sun; Albert H Kim
Journal:  Cancer Metastasis Rev       Date:  2022-08-03       Impact factor: 9.237

2.  Differential gene expression analysis using RNA sequencing: retinal pigment epithelial cells after exposure to continuous-wave and subthreshold micropulse laser.

Authors:  Tomoyasu Shiraya; Fumiyuki Araki; Suguru Nakagawa; Takashi Ueta; Kiyohito Totsuka; Hitoshi Abe; Yasuyuki Naito; Taku Toyama; Koichiro Sugimoto; Satoshi Kato
Journal:  Jpn J Ophthalmol       Date:  2022-05-31       Impact factor: 2.211

Review 3.  Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment.

Authors:  Wiam El Kheir; Bernard Marcos; Nick Virgilio; Benoit Paquette; Nathalie Faucheux; Marc-Antoine Lauzon
Journal:  Pharmaceutics       Date:  2022-06-01       Impact factor: 6.525

4.  Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.

Authors:  Anne-Florence Blandin; Elisabete Cruz Da Silva; Marie-Cécile Mercier; Oleksandr Glushonkov; Pascal Didier; Stéphane Dedieu; Cristophe Schneider; Jessica Devy; Nelly Etienne-Selloum; Monique Dontenwill; Laurence Choulier; Maxime Lehmann
Journal:  Cell Mol Life Sci       Date:  2020-11-05       Impact factor: 9.261

Review 5.  Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.

Authors:  Motomichi Fujita; Manabu Sasada; Takuya Iyoda; Fumio Fukai
Journal:  Molecules       Date:  2020-07-16       Impact factor: 4.411

6.  Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric H3.3-Mutated Gliomas Recreate the Patient Tumor Complexity.

Authors:  Anne-Florence Blandin; Aurélie Durand; Marie Litzler; Aurélien Tripp; Éric Guérin; Elisa Ruhland; Adeline Obrecht; Céline Keime; Quentin Fuchs; Damien Reita; Benoit Lhermitte; Andres Coca; Chris Jones; Isabelle Lelong Rebel; Pascal Villa; Izzie Jacques Namer; Monique Dontenwill; Dominique Guenot; Natacha Entz-Werle
Journal:  Cancers (Basel)       Date:  2019-11-26       Impact factor: 6.639

Review 7.  Research advances on structure and biological functions of integrins.

Authors:  Li Pan; Yuan Zhao; Zhijie Yuan; Guixin Qin
Journal:  Springerplus       Date:  2016-07-15

8.  Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.

Authors:  Guillaume Renner; Fanny Noulet; Marie-Cécile Mercier; Laurence Choulier; Nelly Etienne-Selloum; Jean-Pierre Gies; Maxime Lehmann; Isabelle Lelong-Rebel; Sophie Martin; Monique Dontenwill
Journal:  Oncotarget       Date:  2016-09-20

9.  RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.

Authors:  Sabrina Boyrie; Caroline Delmas; Anthony Lemarié; Vincent Lubrano; Perrine Dahan; Laure Malric; José Luis; Julia Gilhodes; Marie Tosolini; Laetitia Mouly; Maxime Lehmann; Christine Toulas; Elizabeth Cohen-Jonathan Moyal; Sylvie Monferran
Journal:  Oncotarget       Date:  2018-09-18

10.  Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin.

Authors:  Saidu Sani; Nikita Pallaoro; Mélissa Messe; Chloé Bernhard; Nelly Etienne-Selloum; Horst Kessler; Luciana Marinelli; Natacha Entz-Werle; Sophie Foppolo; Sophie Martin; Damien Reita; Monique Dontenwill
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.